Senior Director, Statistical Methodologist
Biogen- Full Time
- Senior (5 to 8 years)
WELCOME to Aetion! We are one of the country’s leading science-driven technology companies using real-world evidence for better healthcare decision-making. Our Generate, Discover and Substantiate applications, powered by the Aetion Evidence Platform, evaluate the safety, effectiveness, and value of medications, delivering better outcomes to patients, medical professionals, and clients. We’ve partnered with top biopharma companies and are backed by leading venture capital firms to help increase our medical research and expand our product line. Aetion has entered into an agreement to be acquired by Datavant, a leading health data platform company. Learn more.
As a science-driven healthcare analytics company with a rapidly growing customer base, Aetion is looking for an experienced biostatistician with expertise in biostatistics and/or epidemiologic methods applied to real world data, as well as R programming and managing teams.
As a Senior Director in the Research+Analytics team, you will hold an active people manager role. As a successful candidate, you will manage a team of R programmers executing analyses for client projects, serve as a statistical/epidemiologic expert in applied research activities, champion methodologic research, and contribute to the development of software product features.
This position will report to the Head of Research+Analytics, Chief Science Office.
Software solutions for real-world evidence analysis
Aetion develops software solutions that utilize real-world evidence (RWE) to assist life sciences companies, regulators, and purchasers in making informed decisions. Their software analyzes real-world data to provide insights into the effectiveness and safety of medical innovations, from initial hypotheses to long-term monitoring. Aetion's clients include major pharmaceutical companies and healthcare regulators, who benefit from the ability to generate and analyze diverse data sets for clinical insights that were previously hard to obtain. The company differentiates itself by offering a platform that not only manages longitudinal data but also generates synthetic health data using artificial intelligence. Aetion's goal is to maximize the return on investment for its clients by providing rapid insights that facilitate critical decision-making, ultimately expediting patient care and treatment options.